| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
283,666 | 305,626 | 313,855 | 296,590 | 293,742 |
| Cost of Revenue
|
-167,284 | -188,461 | -190,619 | -180,208 | -178,166 |
|
Gross Profit
|
116,382 | 117,165 | 123,236 | 116,382 | 115,576 |
|
Selling, General and Administrative Expenses
|
-79,291 | -90,519 | -78,546 | -65,942 | -60,979 |
|
Operating Income/Expenses
|
-79,291 | -90,519 | -78,546 | -65,942 | -60,979 |
|
Total Operating Profit/Loss
|
37,091 | 26,646 | 44,690 | 50,440 | 54,597 |
| Total Net Finance Income/Expense
|
-4,083 | -1,716 | -1,594 | -3,235 | -144 |
| Irregular Income/Expenses
|
-3,881 | -3,112 | -102 | -1,178 | 651 |
|
Non-Operating Income/Expenses, Total
|
-7,964 | -4,828 | -1,696 | -4,413 | 507 |
|
Pretax Income
|
29,127 | 21,818 | 42,994 | 46,027 | 55,104 |
|
Provision for Income Tax
|
-11,288 | -8,875 | -13,364 | -11,876 | -14,302 |
|
Net Income from Continuing Operations
|
17,839 | 12,943 | 29,630 | 34,151 | 40,802 |
|
Discontinued Operations
|
-- | -- | -- | 0 | 0 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
17,839 | 12,943 | 29,630 | 34,151 | 40,802 |
|
Net Income after Non-Controlling/Minority Interests
|
17,839 | 12,943 | 29,630 | 34,151 | 40,802 |
|
Net Income Available to Common Stockholders
|
17,839 | 12,943 | 29,630 | 34,151 | 40,802 |
|
Diluted Net Income Available to Common Stockholders
|
17,839 | 12,943 | 29,630 | 34,151 | 40,802 |
|
Common Dividend per Share
|
0.48 | 0.48 | 0.44 | 0.44 | 0.44 |
| Basic EPS
|
0.70 | 0.47 | 1.08 | 1.26 | 1.30 |
| Diluted EPS
|
0.70 | 0.46 | 1.05 | 1.24 | 1.28 |
|
Basic Weighted Average Shares Outstanding
|
25,458.77 | 27,305 | 27,560 | 27,170 | 31,399.81 |
|
Diluted Weighted Average Shares Outstanding
|
25,630.90 | 27,907 | 28,091 | 27,637 | 31,961.74 |
|
Reported Normalized Diluted EPS
|
1.47 | 1.55 | 1.68 | 1.55 | 1.50 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
33,210 | 23,534 | 44,588 | 49,262 | 55,248 |
|
EBITDA
|
38,928 | 28,714 | 48,506 | 52,683 | 58,685 |
|
Normalized EBITDA
|
58,365 | 62,675 | 68,151 | 64,989 | 66,948 |
|
Normalized Income
|
37,717 | 43,320 | 47,278 | 42,964 | 48,010 |
|
Total Unusual Items
|
19,437 | 33,961 | 19,645 | 12,306 | 8,263 |
|
Total Unusual Items Excluding Goodwill
|
19,437 | 33,961 | 19,645 | 12,306 | 8,263 |
12/31/2022 - 5/28/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade